safety and quality in anaesthetic practice Flashcards
(141 cards)
The rank of volatile anaesthetic agents from highest to lowest derived global
warming potential over 100 years (GWP100) is:
a) Nitrous, des, iso, sevo
b) Des, iso, nitrous, sevo
c) Des, nitrous, iso, sevo
d) Nitrous, des, sevo, iso
B
Desflurane (Des): GWP100 around 2,500-3,000
Isoflurane (Iso): GWP100 around 1,000-1,100
Nitrous oxide (Nitrous): GWP100 around 298
Sevoflurane (Sevo): GWP100 around 130-210
Organ procurement after circulatory death is generally stood down if the time from
cessation of cardiorespiratory support to circulatory death extends beyond:
a) 60min
b) 90min
c) 120min
90 mins
30mins
Liver
Pancreas
Heart
60mins
Kidneys
90mins
Lungs
Page 35 ANZICS statement 2.4.3 Warm ischemia time
Donate life
The most appropriate order of blood products transfused sequentially through the
same blood administration set is:
A) RBC - plasma - plts
B) RBC - plts - plasma
C) Plasma - RBC - plts
D) Plts- RBC -plasma
D) Plts- RBC -plasma
according to Lifeblood guidelines, platelets MUST be given before RBC if in the same line, as red cell debris will trap platelets; platelets and plasma can be sequential through the same set; as platelets take a long time to transfuse, it makes sense to first transfuse plasma (fast), then platelets, then red cells
The muscle recommended for neuromuscular monitoring by the 2023 American
Society of Anesthesiologists practice guidelines is the:
a) Adductor Pollicis
b) Flexor pollicis longus
c) Flexor hallucis brevis
d) Corrugator supercilii
e) Orbicularis oculi
A - Adductor Pollicis - Usual site for NMT
Correct on ASA website
In the event of an electrical fire in the operating room, the correct fire extinguisher
type to use is:
a) Dry powder
b) Wet
c) Chemical
d) CO2
CO2
Pull/Aim/Squeeze/Sweep
Don’t use fire blankets - concentrated heat on patient
Saline or water for body cavity fire
Dry powder and chemical can leave residues that could damage equipment
According to the ISO colour code for medical gas cylinders, Entonox is indicated by
a) Blue/ White
b) Yellow
c) Black
d) Grey
a) Blue/ White
Blue and white shoulder
White bottle
Pre 2004 made cylinder is blue
The minimum age in years for in vitro contracture testing for suspected malignant
hyperthermia is
a) 6
b) 8
c) 10
d) 12
10
All current Australian and New Zealand laboratories follow the guidelines of the European Malignant Hyperthermia Group for In Vitro Contracture Testing.
The EMHG guidelines are summarised as follows:
Age and Weight
The minimum weight limit for Australian and New Zealand laboratories is 30 kg and the minimum age for IVCT is 10 years.
(Emhg actually says min age for muscle biopsy is 4 yrs but lab’s should not test children under 10 yrs without relevant control data)
IVCT details
The biopsy should be performed on the quadriceps muscle (eithervastus medialisorvastuslateralis), using local (avoiding local anaesthetic infiltration of muscle tissue), regional, or trigger-free general anaesthetic techniques.
The muscle samples can be dissected in vivo or removed as a block for dissection in the laboratory within 15 minutes.
The time from biopsy to completion of the tests should not exceed 5 hours.
Muscle specimens should measure 20-25 mm in length and at least four tests should be performed each one using a fresh specimen.
The tests should include a static cumulative caffeine test and a dynamic or static halothane test.
The results should be reported as the threshold concentration, which is the lowest concentration of caffeine or halothane that produces a sustained increase of at least 2 mN (0.2 grams) in baseline force from the lowest force reached.
In Australia and New Zealand, a return to practice program is recommended after an absence from consultant anaesthetic practice for more than:
a) 3 months
b) 6 months
c) 9 months
d) 12 months
12 months
A drug which is unlikely to interfere with skin testing is oral:
a) Diphenhydramine
b) Amitriptyline
c) Prednisolone
d) Risperidone
e) Ranitidine
MAYANK Risperidone
Avoid antihistamines and steroids
TCAs known to interfere
Mayo clinic website
See allergy.org.au - risp mentioned in appendix b as a med that may need held
According to the ANZCA guideline on fatigue risk management in anaesthesia practice the duration of an ideal nap is:
a) 10-20
b) 20-30
c) 40-50
MAYANK 20-30 mins
ANZCA PG43a
The clinical laser type with the greatest tissue penetration is:
a) Argon
b) Nd:yag
c) Some other yag
d) Co2
e) Holmium
b) Nd:yag
Modified Question: this question asks Greatest, old asks least
Least = CO2
Most = Nd:Yag
CO2 laser has very little penetration (~ 10micrometres), as it has a wavelength of 10 600nm.
Helium-Neon laser also has very little penetration.
Nd:YAG is the most powerful, with a penetration of 2-6mm, as it has a wavelength of 1064nm.
According to the 5th National Audit Project (NAP5), the incidence of awareness during general anaesthesia using a non-relaxant technique with a volatile agent is approximately:
a. 1:700
b. 1:8000
c. 1:10000
d. 1:19000
e. 1:136,000
REPEAT
e. 1:136,000
https://www.bjanaesthesia.org/article/S0007-0912%2817%2930746-8/fulltext
1/670 E-LSCS
1/8000 with muscle relaxation
1/8600 CTS
1/8200 Volatile + neuromuscular blocking
Overall 1:19000
According to the RELIEF study, in major abdominal surgery a liberal fluid strategy
(10 mL/kg of crystalloid at induction followed by 8 mL/kg/hour during the case)
compared to a restrictive fluid strategy, results in:
A. Increased bowel anastomosis breakdown
B. Increased mortality
C. Decreased mortality
D. No difference in wound infection
E. Decreased acute kidney injury
REPEAT
E. Decreased acute kidney injury
Restrictive had more AKI
Otherwise no outcome significant statistically
https://www.thebottomline.org.uk/summaries/relief/
A patient with known suxamethonium allergy is most likely to demonstrate cross reactivity with:
a. Mivacurium
b. Cisatracurium
c. Atracurium
d. Rocuronium
e. Cephazolin
REPEAT
AT - Rocuronium
Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011 by Sadleir et al
(This paper was referenced in NAP 6 “Cross-sensitivity, based on skin testing and specific IgE, is common, with suxamethonium being the most commonly crossreacting drug (Sadleir 2013).”)
Fig 4 shows Rates of cross-reactivity for patients diagnosed with anaphylaxis according to the triggering NMBD.
- for sux anaphylaxis: highest cross-reactivity was roc (24%), then interestingly vec and cis were both tied at 12%, as were panc and atrac at 6%
PREVIOUS NOTES:
BJA Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011
https://academic.oup.com/bja/article/110/6/981/245571
Rocuronium has a higher rate of IgE-mediated anaphylaxis compared with vecuronium, a result that is statistically significant and clinically important.
Cisatracurium had the lowest rate of cross-reactivity in patients who had previously suffered anaphylaxis to rocuronium or vecuronium.
Anaphylaxis rates (highest to lowest)
Primary anaphylaxis: rocuronium > atracurium > vecuronium > pancuronium = cisatracurium
Cross-reactivity: suxamethonium > rocuronium > vecuronium > pancuronium > atracurium > cisatracurium
The image below shows results from non-inferiority trials. The trial labelled ‘M’ is best described as:
a) Non inferiority graph (line crossed the 0 line but not non-inferior dotted line)
NIKKI
Analysis of variance (ANOVA) is a statistical test to determine:
a) The validity between an expected and observed outcome in a population
b) The difference between the means of more than two populations
c) The difference between two populations with non-parametric data
d) The degree of similarity of the median between two or more populations
e) If the variance within a population is likely to be abnormally or normally distributed
REPEAT
B) analyse the difference between the means of more than two groups
In pulmonary function testing the presence of airflow limitation is defined by a post- bronchodilator FEV1/FVC ratio less than:
a) 0.5
b) 0.6
c) 0.7
d) 0.8
c) 0.7
Local anaesthetic-induced myotoxicity is most likely to be associated with:
A. Biers
B. Interscalene
C. Sciatic
D. Adductor Canal
REPEAT
D. Adductor Canal
unclear phenomonenon
prolonged exposure and high concentrations of local anaesthetic
Regarding healthcare research, the PICO framework describes:
a) Critical appraisal
b) Meta-analysis
c) Observational study
d) Systematic review
REPEAT
a) Critical appraisal
PICO is a mnemonic used to describe the four elements of a good clinical foreground question:
P = Population/Patient/Problem - How would I describe the problem or a group of patients similar to mine?
I = Intervention - What main intervention, prognostic factor or exposure am I considering?
C = Comparison - Is there an alternative to compare with the intervention?
O = Outcome - What do I hope to accomplish, measure, improve or affect?
Kate According to the Australian and New Zealand Committee on Resuscitation guidelines, the minimum distance a defibrillation pad should be placed away from a pacemaker or implantable cardiac defibrillator generator is:
a) 8cm
b) 12cm
c) 16cm
A) 8cm
ANZCOR:
In patients with an ICD or a permanent pacemakerthe defibrillator pad/paddle is placed on the chest wall ideally at least 8 cm from the generator position
Kate For driving pressure guided ventilation, driving pressure is the:
a) Pplat-peep
b) Peak pressure-peep
c) Other formulas
Pplat-PEEP
driving pressure is defined as distending pressure above the applied Peep Required to generate Vt
- key variable for optimisation when performing mechanical ventilation in ARDS
- also Vt/CRS (Ratio of Tidal volume to static resp system compliance)
23.1 You are planning to extubate a patient following airway surgery. The patient has FAILED the cuff-leak test when
a. <110ml leak with cuff deflated
b. >110ml leak with cuff deflated
c. Audible leak with cuff deflated
d. No audible leak with cuff deflated
e. No audible leak with cuff pressure <30cm H2O
a. <110ml leak with cuff deflated
approach is to use 110 mL or 10% of tidal volume as the cut-off
https://litfl.com/cuff-leak-test/
21.1 Infection control management of patients with carbapenemase-producing Enterobacteriaceae (CPE)
infection should include all of the following EXCEPT
a) isolation
b) contact precautions
c) droplet precautions
d) screening at risk patients with rectal swab and urine mcs
c) droplet precautions
https://www.safetyandquality.gov.au/sites/default/files/migrated/Recommendations-for-the-control-of-Carbapenemase-producing-Enterobacteriaceae.pdf